PubMed

The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade.

Makhlouf L, Kishimoto K, Smith RN, Abdi R, Koulmanda M, Winn HJ, Auchincloss H Jr, Sayegh MH.

Diabetes. 2002 Nov;51(11):3202-10.PMID: 12401711 [PubMed - indexed for MEDLINE]Related articlesFree article

MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.

Kupfer TM, Crawford ML, Pham K, Gill RG.

J Immunol. 2005 Aug 15;175(4):2309-16.PMID: 16081800 [PubMed - indexed for MEDLINE]Related articlesFree article

Recurrent autoimmunity accelerates destruction of minor and major histoincompatible islet grafts in nonobese diabetic (NOD) mice.

Okitsu T, Bartlett ST, Hadley GA, Drachenberg CB, Farney AC.

Am J Transplant. 2001 Jul;1(2):138-45.PMID: 12099361 [PubMed - indexed for MEDLINE]Related articles

Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.

Guo Z, Wu T, Kirchhof N, Mital D, Williams JW, Azuma M, Sutherland DE, Hering BJ.

Transplantation. 2001 Jun 15;71(11):1656-65.PMID: 11435979 [PubMed - indexed for MEDLINE]Related articles

Prevention of autoimmune islet allograft destruction by engraftment of donor T cells.

Bartlett ST, Schweitzer EJ, Kuo PC, Johnson LB, Delatorre A, Hadley GA.

Transplantation. 1997 Jan 27;63(2):299-303.PMID: 9020334 [PubMed - indexed for MEDLINE]Related articles

"Indirect" acute islet allograft destruction in nonobese diabetic mice is independent of donor major histocompatibility complex and requires host B lymphocytes.

Kupfer T, Beilke JN, Pham K, Buhrman J, Gill RG.

Transplant Proc. 2008 Mar;40(2):462-3.PMID: 18374102 [PubMed - indexed for MEDLINE]Related articles

Differences in suppressor of cytokine signaling-1 (SOCS-1) expressing islet allograft destruction in normal BALB/c and spontaneously-diabetic NOD recipient mice.

Solomon M, Flodström-Tullberg M, Sarvetnick N.

Transplantation. 2005 May 15;79(9):1104-9.PMID: 15880051 [PubMed - indexed for MEDLINE]Related articles

A major role for host MHC class I antigen presentation for promoting islet allograft survival.

Beilke J, Johnson Z, Kuhl N, Gill RG.

Transplant Proc. 2004 May;36(4):1173-4.PMID: 15194406 [PubMed - indexed for MEDLINE]Related articles

Indefinite survival of MHC class I-deficient murine pancreatic islet allografts.

Markmann JF, Bassiri H, Desai NM, Odorico JS, Kim JI, Koller BH, Smithies O, Barker CF.

Transplantation. 1992 Dec;54(6):1085-9.PMID: 1465773 [PubMed - indexed for MEDLINE]Related articles

Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice.

Seung E, Iwakoshi N, Woda BA, Markees TG, Mordes JP, Rossini AA, Greiner DL.

Blood. 2000 Mar 15;95(6):2175-82.PMID: 10706892 [PubMed - indexed for MEDLINE]Related articlesFree article

Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.

Ansari MJ, Fiorina P, Dada S, Guleria I, Ueno T, Yuan X, Trikudanathan S, Smith RN, Freeman G, Sayegh MH.

Clin Immunol. 2008 Feb;126(2):140-7. Epub 2007 Sep 24.PMID: 17889619 [PubMed - indexed for MEDLINE]Related articles

Allogeneic chimerism induces donor-specific tolerance to simultaneous islet allografts in nonobese diabetic mice.

Li H, Kaufman CL, Ildstad ST.

Surgery. 1995 Aug;118(2):192-7; discussion 197-8.PMID: 7638733 [PubMed - indexed for MEDLINE]Related articles

Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.

Saborio DV, Chowdhury NC, Jin MX, Chandraker A, Sayegh MH, Oluwole SF.

Cell Transplant. 1999 Jul-Aug;8(4):375-81.PMID: 10478717 [PubMed - indexed for MEDLINE]Related articles

Pig islet xenografts are resistant to autoimmune destruction by non-obese diabetic recipients after anti-CD4 treatment.

Koulmanda M, Qipo A, Smith RN, Auchincloss H Jr.

Xenotransplantation. 2003 Mar;10(2):178-84.PMID: 12588650 [PubMed - indexed for MEDLINE]Related articles

Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation.

Molano RD, Berney T, Li H, Cattan P, Pileggi A, Vizzardelli C, Kenyon NS, Ricordi C, Burkly LC, Inverardi L.

Diabetes. 2001 Feb;50(2):270-6.PMID: 11272136 [PubMed - indexed for MEDLINE]Related articlesFree article

Role of donor MHC class III genes in the destruction of transplanted islets in NOD mice.

Jevnikar AM, Prange S, Zucker P, Singh B.

Ann N Y Acad Sci. 2002 Apr;958:175-8.PMID: 12021101 [PubMed - indexed for MEDLINE]Related articles

Idd loci synergize to prolong islet allograft survival induced by costimulation blockade in NOD mice.

Mangada J, Pearson T, Brehm MA, Wicker LS, Peterson LB, Shultz LD, Serreze DV, Rossini AA, Greiner DL.

Diabetes. 2009 Jan;58(1):165-73. Epub 2008 Nov 4.PMID: 18984741 [PubMed - indexed for MEDLINE]Related articlesFree article

Characterization of the role of major histocompatibility complex in type 1 diabetes recurrence after islet transplantation.

Young HY, Zucker P, Flavell RA, Jevnikar AM, Singh B.

Transplantation. 2004 Aug 27;78(4):509-15.PMID: 15446308 [PubMed - indexed for MEDLINE]Related articles

Autoimmune destruction of islet grafts in the NOD mouse is resistant to 15-deoxyspergualin but sensitive to anti-CD4 antibody.

Stegall MD, Loberman Z, Ostrowska A, Coulombe M, Gill RG.

J Surg Res. 1996 Aug;64(2):156-60.PMID: 8812627 [PubMed - indexed for MEDLINE]Related articles

Transplanted MHC class I-deficient nonobese diabetic mouse islets are protected from autoimmune injury in diabetic nonobese recipients.

Prange S, Zucker P, Jevnikar AM, Singh B.

Transplantation. 2001 Apr 15;71(7):982-5.PMID: 11349735 [PubMed - indexed for MEDLINE]Related articles